RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2024.100051
Elena Cortés-Vicente , Raquel Hernández , Eva Martínez , Julio Pardo , Francisco Javier Rodríguez de Rivera , on behalf of the Neuromuscular Diseases Study Group (GEEN) of the Spanish Society of Neurology
{"title":"Consensus recommendation for the treatment of generalised Myasthenia Gravis with anti-acetylcholine receptor antibodies (gMG AChR+) in Spain","authors":"Elena Cortés-Vicente , Raquel Hernández , Eva Martínez , Julio Pardo , Francisco Javier Rodríguez de Rivera , on behalf of the Neuromuscular Diseases Study Group (GEEN) of the Spanish Society of Neurology","doi":"10.1016/j.rare.2024.100051","DOIUrl":"10.1016/j.rare.2024.100051","url":null,"abstract":"<div><div>Myasthenia Gravis (MG) is a rare, chronic, and autoimmune neuromuscular disease caused by presence of pathogenic immunoglobulins G (IgG) targeting postsynaptic components of the neuromuscular junction resulting in muscle weakness and fatigability. Currently therapies for MG are focused on improving clinical symptoms aiming to achieve remission or minimal expression of symptoms. Immunologically, 85 % of patients with generalised MG (gMG) have autoantibodies against the acetylcholine receptor (AChR+). In Spain, several reviews on MG treatment have been published, but the approval of new molecules with more targeted mechanisms of action indicated for gMG AChR+ makes necessary to update the current treatment protocol to reflect the latest evidence and align it with current recommendations from national and international clinical practice.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100051"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2024.100057
Tudor Groza , Chun-Hung Chan , David A. Pearce , Gareth Baynam
{"title":"Realising the potential impact of artificial intelligence for rare diseases – A framework","authors":"Tudor Groza , Chun-Hung Chan , David A. Pearce , Gareth Baynam","doi":"10.1016/j.rare.2024.100057","DOIUrl":"10.1016/j.rare.2024.100057","url":null,"abstract":"<div><div>Rare diseases (RD) are conditions affecting fewer than 1 in 2000 persons, with over 7000 largely genetic RDs affecting 3.5 %-5.9 % of the global population, or approximately 262.9–446.2 million people. The substantial healthcare burden and costs, such as the $1 trillion annual expense in the USA, highlight the urgent need for improved RD management. The International Rare Diseases Research Consortium (IRDiRC) addresses this need through global collaboration, aiming for timely and accurate diagnosis, development of 1000 new therapies, and methodologies to measure impact by 2027.</div><div>IRDiRC's initiatives include biannual meetings and workshops, like the AI-focused workshop in October 2023. This identified AI as crucial for advancing RD research and proposed a Framework for AI to enhance the RD patient journey by addressing efficiency and quality of life through modular solutions mapped to critical stages. The Framework integrates diverse data sources to improve diagnosis, treatment, and impact assessment, reflecting a holistic, cross-sector approach. By guiding multi-stakeholder efforts, the Framework aims to harness AI’s potential to significantly improve rare disease care.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100057"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100087
Morten Reiffenstein Huno , Trine Østergaard Nielsen , Michel Bach Hellfritzsch , Sara Markholt , Michael Davidsen , Stine Maria Lund Andersen , Sia Mariann Kjeldsen , Thomas Krusenstjerna-Hafstrøm , Stephen P. Robertson , Pernille Axél Gregersen
{"title":"Frontometaphyseal dysplasia associated with the FLNA p.G1576R variant","authors":"Morten Reiffenstein Huno , Trine Østergaard Nielsen , Michel Bach Hellfritzsch , Sara Markholt , Michael Davidsen , Stine Maria Lund Andersen , Sia Mariann Kjeldsen , Thomas Krusenstjerna-Hafstrøm , Stephen P. Robertson , Pernille Axél Gregersen","doi":"10.1016/j.rare.2025.100087","DOIUrl":"10.1016/j.rare.2025.100087","url":null,"abstract":"<div><div>This report presents a male patient with frontometaphyseal dysplasia (FMD) caused by a previously reported <em>FLNA</em> variant (NM_001456.4:c.4726G>A (p.Gly1576Arg)) that was maternally inherited. This finding directly contrasts with two previously reported observations of the same variant, which led to the suggestion that it is associated with a clinically distinct phenotype. Unlike these earlier descriptions, which did not report either signs of skeletal dysplasia or the typical facial features of FMD, the individual we report here exhibits, supraorbital hyperostosis, a skeletal dysplasia (small femoral epiphyses and bilateral pes cavus), retentio testis, reduced joint mobility, and a congenital cardiac anomaly (Ebstein anomaly). Furthermore, the previous cases documented uric acid renal stones and increased optic cup-to-disc ratio, both of which are not found in this patient. The previously reported individuals also had prominent keloid scarring, that is commonly encountered in individuals with FMD, but notably our patient exhibited hypertrophic scarring. The phenotype we report here suggests a broader phenotypic spectrum associated with this specific <em>FLNA</em> variant than previously recognized, challenging the view that it represents a separate syndrome of cardiac valvulopathy, keloid scarring, and joint mobility reduction and instead suggests it is likely best included within the spectrum of frontometaphyseal dysplasia.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100087"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143887018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100089
José M. Lazaro-Guevara , Karen M. Garrido-Lopez
{"title":"Siblings with Rett Syndrome: A fatal male case and an asymptomatic female carrier","authors":"José M. Lazaro-Guevara , Karen M. Garrido-Lopez","doi":"10.1016/j.rare.2025.100089","DOIUrl":"10.1016/j.rare.2025.100089","url":null,"abstract":"<div><h3>Background</h3><div>Rett Syndrome (RTT) is an X-linked dominant neurodevelopmental disorder, primarily affecting females. It was previously believed that male cases, although rare, frequently result in severe symptoms and early mortality due to hemizygosity of the X chromosome. However, recent studies show that some males with <em>MECP2</em> variants may present with a broad phenotypic spectrum, including milder forms, as well as a broader spectrum in affected females due to the effect of X-inactivation that previously was underrecognized.</div></div><div><h3>Case presentation</h3><div>We report RTT in two siblings from the same parents, both carrying a pathogenic <em>MECP2</em> mutation (c.763 C>T, p.Arg255*). The male sibling presented early hypotonia, profound developmental delays, and died in infancy. Initially presumed to be a de novo mutation, subsequent expanded genetic testing revealed the mother to be an asymptomatic carrier—likely attributable to favorable or skewed X chromosome inactivation. She had inherited this mutation neither from her father nor her mother, as both maternal grandparents tested negative. Despite two in vitro fertilization (IVF) attempts with preimplantation genetic diagnosis (PGD) in Guatemala (ultimately unsuccessful), the couple conceived naturally. Their female child, who carries the same <em>MECP2</em> mutation, remains asymptomatic at 27 months, demonstrating typical developmental milestones.</div></div><div><h3>Conclusion</h3><div>These findings underscore the broad phenotypic spectrum of RTT, with markedly different clinical outcomes—for this specific case fatal in the hemizygous male and asymptomatic in the female carrier. They also highlight critical considerations for genetic counseling, the financial and emotional challenges inherent in assisted reproductive technologies in resource-limited settings, and the importance of ongoing surveillance for carriers of <em>MECP2</em> mutations due to risk of developing subtle or late-onset features.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100089"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143891920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100073
Marcela Vela-Amieva, Cynthia Fernández-Lainez
{"title":"Correspondence on “First year result and insights from the Mexican Rare Disease Patient Registry from Cesar E. Calvo Aspiros and Claudia Gonzaga-Jauregui, which was recently published on Rare journal. https://doi.org/10.1016/j.rare.2024.100046","authors":"Marcela Vela-Amieva, Cynthia Fernández-Lainez","doi":"10.1016/j.rare.2025.100073","DOIUrl":"10.1016/j.rare.2025.100073","url":null,"abstract":"","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100073"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143552306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100079
Ru Jian Jonathan Teoh , Kala Sumugam , Sharifah Intan Hosnaliza Syed Osman , Hairuddin Achmad , Nor Aizan Ab’llah @ Ariffin
{"title":"Optic nerve hemangioblastoma mimicking optic pathway glioma: A case report and literature review","authors":"Ru Jian Jonathan Teoh , Kala Sumugam , Sharifah Intan Hosnaliza Syed Osman , Hairuddin Achmad , Nor Aizan Ab’llah @ Ariffin","doi":"10.1016/j.rare.2025.100079","DOIUrl":"10.1016/j.rare.2025.100079","url":null,"abstract":"<div><div>Optic nerve hemangioblastomas (ONH) are rare tumors frequently associated with Von Hippel-Lindau (VHL) syndrome. They may mimic optic pathway gliomas (OPG), posing diagnostic and surgical challenges. We report a case of a 36-year-old male presenting with progressive blurry vision in the right eye over three months. Initial examination revealed unilateral axial proptosis, a positive relative afferent pupillary defect, and optic disc swelling. Initial magnetic resonance imaging revealed a lobulated, enhancing lesion involving the intra-orbital segment of the right optic nerve, which was presumed to be an OPG. Over five years of surveillance, the tumor progressed, causing new-onset headaches, worsening proptosis, and mass effect. Surgical debulking was performed, revealing a hemangioblastoma histologically. ONH should be considered in the differential diagnosis of optic pathway tumors, particularly in cases with atypical presentation or progression. Surgical intervention may be necessary for definitive diagnosis and management, and an association with VHL must be considered.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100079"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143807122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100068
Jayeshkumar Kanani, Mohammed Iliyas Sheikh
{"title":"Breaking patterns: Multiple spleens and the absent right kidney—A rare and unique case report in a 33-year-old burn victim","authors":"Jayeshkumar Kanani, Mohammed Iliyas Sheikh","doi":"10.1016/j.rare.2025.100068","DOIUrl":"10.1016/j.rare.2025.100068","url":null,"abstract":"<div><div>Polysplenia is a congenital condition characterized by the presence of multiple small accessory spleens with absent of primary spleen. While polysplenia may occur in isolation or may be present as part of Polysplenia syndrome. This report presents an extraordinary case of polysplenia in a 33-year-old male who died due to severe burns, and an autopsy was performed. During the medicolegal autopsy, internal examination showed three spleen-like structures without a primary spleen, along with the absence of the kidney on the right side. Despite these anomalies, blood investigations that were conducted during treatment revealed normal organ function. The deceased had no history of a major illness or surgery. This rare combination in adults has never been reported in the literature. This unique case contributes to the complexity of polysplenia syndrome and challenges conventional diagnostic expectations. This particular case doesn't fit to polysplenia syndrome. This condition may predispose individuals to increased health risks, such as infections or renal complications, emphasizing the importance of thorough medical evaluation and follow-up. This case underlines the significance of imaging studies and physical examinations in identifying congenital anomalies that might remain asymptomatic but could have future clinical implications.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100068"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143395528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100060
Ben Green
{"title":"Methodological considerations and implications for appetite and feeding behaviour research in PKU; Current knowledge, practical application and future perspectives","authors":"Ben Green","doi":"10.1016/j.rare.2025.100060","DOIUrl":"10.1016/j.rare.2025.100060","url":null,"abstract":"<div><div>Appetite and the regulation of feeding behaviour are sophisticated processes. Regulated through homeostatic and non-homeostatic influences, appetite-related peptides and external cues existing in the physical environment work synergistically to maintain energy homeostasis. Phenylketonuria (PKU) is a rare disorder impacting phenylalanine metabolism. The disrupted breakdown of phenylalanine into tyrosine and its metabolites may impact the mechanisms controlling appetite and feeding behaviour compared to non-PKU counterparts. This may, in part, relate to consumption of L-amino acid protein substitutes and specialist low-protein foods which are integral adjuncts to the dietary management of PKU. While adequate energy intake is an important factor for maintaining satisfactory blood phenylalanine concentrations, appetite and feeding behaviour should, therefore, represent an integral consideration for PKU but is currently understudied. Only a handful of studies have evaluated appetite and feeding behaviour in PKU. The most appropriate methodological approaches of these studies however were not employed. This manuscript, therefore, reviews the purported mechanisms controlling appetite and feeding behaviour and from a PKU perspective provides readers with sound study design proposals and justification. Though one method will not answer all research questions, this manuscript may help researchers and practitioners make informed decisions about what tools and methodological approaches will provide the most meaningful outcomes. The manuscript concludes with suggestions for future research directions. Though the evidence concerning appetite and feeding behaviour in PKU remains equivocal at present, early data appears to indicate that protein substitutes with glycomacropeptide facilitate metabolic control and improve appetite-relate peptide regulation and therefore satiety signalling in PKU.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100060"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143133405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100072
Tanja Zdolšek Draksler , Anne Hugon , Dorica Dan
{"title":"Reflections on the ERN ITHACA 2024 Patient Workshop in Bucharest","authors":"Tanja Zdolšek Draksler , Anne Hugon , Dorica Dan","doi":"10.1016/j.rare.2025.100072","DOIUrl":"10.1016/j.rare.2025.100072","url":null,"abstract":"<div><div>The ERN ITHACA (European reference network for rare malformation syndromes and rare intellectual and neurodevelopmental disorders) Patient Workshop 2024, held on December 12th in Bucharest, Romania, brought together over 70 participants (healthcare providers and patient advocates), to enhance support for individuals with rare genetic diseases. The workshop featured two key segments: Best Practice Sharing, highlighting innovative projects and success stories within the ERN ITHACA patient network, and The Patient Journey, which explored the emotional and psychological challenges faced by patients and families. Breakout discussions focused on building family resilience and addressing grief. Participant feedback was overwhelmingly positive, with a 4.68/5 satisfaction rating, and suggestions for improvement included more interactive exercises and extended workshop duration. The event underscored the importance of collaboration in advancing patient-centred care and will serve as a foundation for the next Patient workshop within ERN ITHACA in December 2025 in Bergen, Norway.</div></div>","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100072"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143510228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RarePub Date : 2025-01-01DOI: 10.1016/j.rare.2025.100076
Sara Brambilla, Gareth Baynam, Roberto Giugliani, Holm Graessner, Carmencita D. Padilla, Chiuhui Mary Wang
{"title":"Improving care for rare and undiagnosed diseases – The role of care pathways","authors":"Sara Brambilla, Gareth Baynam, Roberto Giugliani, Holm Graessner, Carmencita D. Padilla, Chiuhui Mary Wang","doi":"10.1016/j.rare.2025.100076","DOIUrl":"10.1016/j.rare.2025.100076","url":null,"abstract":"","PeriodicalId":101058,"journal":{"name":"Rare","volume":"3 ","pages":"Article 100076"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143685523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}